Calcineurin, Mitochondrial Membrane Potential, and Cardiomyocyte Apoptosis
Jeffery D. Molkentin M itochondria comprise Ϸ30% of the total intracellular volume within a mammalian cardiomyocyte. 1, 2 Not surprisingly, subtle alterations in mitochondrial function or membrane potential can have a dramatic influence on cardiomyocyte energy production and, ultimately, the health of an individual cell. Indeed, cellular injury or stress stimulation directly elicits alterations in mitochondrial architecture, membrane potential, and oxidative capacity, which are associated with an irreversible loss of mitochondrial matrix contents and integral membrane protein constituents such as cytochrome c oxidase. 3 The release of cytochrome c and/or mitochondrial permeability transition directly mediates cellular apoptosis through calcium-sensitive proteases or through coupling proteins that coordinate the activation of caspases and DNA fragmentation enzymes. 3 Given the high intracellular content of mitochondria in cardiomyocytes and the unabated requirement for highenergy phosphate carriers to maintain ionic gradients and active force generation, coordinated disturbances in mitochondrial function can dramatically affect cell survival.
Recent investigation has suggested an emerging paradigm whereby stress-responsive intracellular signaling pathways directly and indirectly influence mitochondrial membrane potential, oxidative capacity, and the coupling of apoptosis initiating factors. For example, stress-responsive signaling through the c-Jun N-terminal kinases (JNKs) has been shown to initiate apoptosis in certain cell types by directly influencing proteins within the mitochondrial membranes. 4 In addition, increased expression of the mitochondrial stabilizing Bcl proteins can be transcriptionally regulated through stressresponsive signaling pathways, which subsequently antagonize mitochondrial dysfunction and cytochrome c release. 5 Activation of the intracellular kinase Akt also directly antagonizes mitochondrial-directed apoptosis by phosphorylating the mitochondrial destabilizing protein Bad, reducing cytochrome c release and caspase activation. 6 Lastly, activation of nuclear factor-B (NF-B) signaling induces expression of stress-adaptive proteins such as Bcl-2, antioxidants, and calcium-regulating proteins. 7 In general, signaling pathways such as the stress-and mitogen-activated protein kinases (SAPKs and MAPKs), protein kinase C (PKC), Akt, NF-B, and the calcium-activated phosphatase calcineurin respond to extracellular stress and/or receptor-activated signal transduction as a means of modulating cell survival against diverse cytopathic stimuli. Given the critical role of mitochondria in cellular homeostasis, additional pathways will likely be elucidated whereby stress-responsive signaling pathways adjust mitochondrial characteristics in an attempt to preserve function, or alternatively, to coordinate cellular apoptosis.
Adult cardiomyocytes are thought to be largely refractory to cell cycle reentry and cytokinesis. 8, 9 Thus, apoptotic events in the myocardium likely result in a cumulative decrease in cell number, which is thought to be a contributing factor in heart failure. 10 The description of apoptosis in the failing myocardium was initially controversial, in part, due to unusually high approximations of overall levels. However, more recent calculations in several animal models of cardiomyopathy, as well as failed human hearts, have confirmed the increased occurrence of cardiomyocyte apoptosis as a potential contributing factor in the progressive loss of pump function. 10 In contrast to the low but cumulative levels of apoptosis identified in the failing heart, acute myocardial infarction promotes massive apoptosis of cardiomyocytes due to a primary lack of oxygen and/or a reperfusion-induced hyperemia that is associated with free radical production. 11 In response to ischemic injury or various forms of cardiomyopathy, many of the stress-responsive signaling pathways discussed above are activated or pathologically regulated. 12 Indeed, stress-responsive signaling pathways not only coordinate alterations in cellular physiology and gene expression, but they also contribute to the regulation of cellular apoptosis.
One potential regulator of stress responses and apoptosis in cardiomyocytes is the calcium/calmodulin-activated protein phosphatase calcineurin (or PP2B). Calcineurin was initially identified as an important regulator of cardiomyocyte hypertrophy in vivo and in vitro. 13, 14 However, more recent investigation has suggested a role for calcineurin in the regulation of cardiomyocyte apoptosis. Such a concept is not unique to cardiomyocytes, as dozens of studies have previously identified a critical role for calcineurin as an effector of apoptosis in other cell types. Studies conducted in neurons, lymphocytes, and cancer cell lines have demonstrated either pro-or antiapoptotic effects of calcineurin activation. [15] [16] [17] [18] [19] [20] [21] [22] The exact decision of cytoprotection versus apoptosis is likely regulated by coordinated signals from other costimulated signaling pathways. Indeed, calcineurin activation was recently shown either to induce apoptosis or to antagonize apoptosis depending on the status of p38 MAPK activation. 23 However, the role that calcineurin plays in regulating cardioThe opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.
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In this issue of Circulation Research, Kakita et al 24 identify an antiapoptotic effect associated with calcineurin activation in cardiomyocytes. Endothelin-1 stimulation of cardiomyocytes was protective against H 2 O 2 -induced TUNEL reactivity, DNA laddering, caspase-3 cleavage, and loss of mitochondrial membrane potential. 24 Endothelin-1 stimulation also promoted NFAT dephosphorylation, which is a highly specific indicator of calcineurin activation. More importantly, endothelin-1-mediated cytoprotection from H 2 O 2 -induced apoptosis was blocked by inhibition of calcineurin with either cyclosporin A or FK506. These results suggest that calcineurin activation normally antagonizes cardiomyocyte apoptosis in response to H 2 O 2 injury. The results of Kakita et al 24 are supported and refuted by two recent studies discussed below.
De Windt et al 14 reported that calcineurin activation protected cardiomyocytes from apoptotic stimulation both in vitro and in vivo, supporting the findings of Kakita et al. 24 Cultured neonatal cardiomyocytes infected with an adenovirus encoding an activated form of calcineurin were protected against 2-deoxyglucose-induced apoptosis. 14 More importantly, transgenic mice expressing an activated form of calcineurin in the heart were largely protected from ischemia/ reperfusion-induced DNA laddering, suggesting that calcineurin activation antagonizes cardiomyocyte apoptosis in vivo. 14 In this same report, cyclosporin A also reversed the protective effects of ␣-adrenergic stimulation in the presence of 2-deoxyglucose treatment in vitro. Collectively, De Windt et al 14 and Kakita et al 24 provide reasonable support for the hypothesis that calcineurin activation is normally cytoprotective in cardiomyocytes.
Molecular mechanisms associated with calcineurinmediated cardioprotection have also been suggested. Kakita et al 24 reported that calcineurin activation promoted an increase in Bcl-2 expression, suggesting a potential mechanism for downregulated apoptosis through enhanced mitochondrial membrane stability. Similarly, De Windt et al 14 reported that calcineurin activation was associated with Akt phosphorylation, which also enhances mitochondrial membrane stability through Bad phosphorylation. However, it is uncertain if calcineurin directly regulates the expression of antiapoptotic cellular machinery, or if calcineurin activation simply antagonizes apoptosis as a secondary consequence of initiating the entire hypertrophic program.
In contrast, Saito et al 25 reported that isoproterenol stimulation of cardiac ␤-adrenergic receptors promoted myocyte apoptosis, in part, by stimulating calcineurin activity. Saito et al 25 demonstrated that cyclosporin A and FK506 blocked the increase in cardiomyocyte apoptosis induced by isoproterenol stimulation and, more significantly, that transgenic mice expressing dominant-negative calcineurin in the heart were refractory to isoproterenol-induced TUNEL reactivity in vivo. These results suggest that calcineurin activation is associated with enhanced apoptosis in cardiomyocytes. However, Saito et al 25 also reported that transgenic mice expressing dominant-negative calcineurin in the heart have increased apoptosis in response to ischemia/reperfusion injury, supporting the contrary hypothesis that calcineurin activation is cardioprotective. These seemingly contradictory data underscore the complexity of intracellular signaling networks within mammalian cells, such that related stress stimuli can elicit fundamentally different responses. Indeed, the most probable explanation for such divergent data, which are even manifested within a single report, is that calcineurin signaling is interpreted within a molecular context of other signaling pathways. This interpretation is also supported by the observed dichotomous role of calcineurin in regulating apoptosis of neurons and lymphocytes discussed above. [15] [16] [17] [18] [19] [20] [21] [22] [23] Given these considerations, calcineurin is likely a more peripheral effector of apoptosis that depends on cellular context and coordinated actions of other signaling pathways.
The assertion that calcineurin can have both anti-and proapoptotic regulatory roles should be considered within context of the multiple mechanisms whereby a cell can undergo apoptosis (mitochondrial-versus death receptormediated). In addition, the interpretation of the role of calcineurin as an apoptotic regulator can be complicated by known side effects of the often-used calcineurin inhibitor cyclosporin A. Most notably, cyclosporin A inhibits mitochondrial destabilization by directly binding to cyclophilin D, which associates with the adenine nucleotide translocator in the inner mitochondrial membrane to regulate permeability pore transition. 26 Indeed, it is not valid to assume that the effects of cyclosporin A on apoptosis are mediated entirely by calcineurin inhibition. For example, cyclosporin A infusion can protect hearts from ischemia/reperfusion-induced injury by preventing mitochondrial permeability transition. 27 That maintaining mitochondrial stability is critical for protecting cardiomyocytes from apoptotic stimuli, such as ischemia/reperfusion, is also highlighted by another report in this issue of Circulation Research. Akao et al 28 demonstrate that maintenance of mitochondrial membrane potential through controlled activation of ATP-sensitive potassium channels prevents oxidative stress-induced cellular apoptosis in cultured cardiomyocytes. Indeed, emerging evidence suggests a paradigm whereby activation of ATP-sensitive potassium channels in the mitochondrial inner membrane can preserve membrane potential and is a significant mechanism of preconditioning-associated cytoprotection. 29, 30 Akao et al 28 demonstrated that H 2 O 2 -induced loss of mitochondrial membrane potential and ensuing apoptosis were antagonized with the ATP-sensitive potassium channel-gating agent diazoxide. Diazoxide-mediated preservation of mitochondrial membrane potential was recently associated with a reversal in mitochondrial matrix contraction and a maintenance in mitochondrial intermembrane volumes, suggesting a structural mechanism underlying the observed protection. 31 Collectively, these results underscore the importance of preserving mitochondrial function and architecture during noxious stimuli as a means of inhibiting cardiomyocyte apoptosis.
In summary, the literature supports a convergence of dissimilar mechanisms to collectively target the mitochondria in an attempt to fine-tune cellular viability in response to pleiotropic insults or agonist stimulation. Indeed, direct effectors of mitochondrial integrity, such as diazoxide and cyclosporin A, can function as potent suppressors of membrane destabilization and the subsequent initiation of apoptosis (although by different mechanisms). Furthermore, an emerging body of literature suggests that intracellular signaling pathways directly and indirectly regulate mitochondrial membrane stability and the apoptotic fate of a cell. Given the central position that mitochondria occupy in cardiomyocytes, future investigations into the mechanisms whereby signaling pathways affect mitochondrial stability will be particularly relevant. Indeed, a better understanding of the molecular effectors that modulate mitochondrial integrity will likely suggest new strategies for protecting cardiomyocytes from ischemic insults.
